The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group
Abstract
Renal impairment is a common complication of multiple myeloma (MM). The estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease formula is the recommended method for the assessment of renal function in patients with MM with stabilized serum creatinine. In acute renal injury, the RIFLE (risk, injury, failure, loss and end-stage kidney disease) and Acute Renal Injury Network criteria seem to be appropriate to define the severity of renal impairment. Novel criteria based on eGFR measurements are recommended for the definition of the reversibility of renal impairment. Rapid intervention to reverse renal dysfunction is critical for the management of these patients, especially for those with light chain cast nephropathy. Bortezomib with high-dose dexamethasone is considered as the treatment of choice for such patients. There is limited experience with thalidomide in patients with myeloma with renal impairment. Thus, thalidomide can be carefully administered, mainly in the context of well-designed clinical trials, to evaluate if it can improve the rapidity and probability of response that is produced by the combination with bortezomib and high-dose dexamethasone. Lenalidomide is effective in this setting and can reverse renal insufficiency in a significant subset of patients, when it is given at reduced doses, according to renal function. The role of plasma exchange in patients with suspected light chain cast nephropathy and renal impairment is controversial. High-dose melphalan (140 mg/m 2) and autologous stem-cell transplantation should be limited to younger patients with chemosensitive disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G., Levin, A., & the Acute Kidney Injury Network (2007) · Critical Care · doi:10.1186/cc5713 · Cited by 7,048
Bellomo, R., Ronco, C., Kellum, J. A., Mehta, R. L., Palevsky, P., & workgroup, T. A. (2004) · Critical Care · doi:10.1186/cc2872 · Cited by 6,781
Levey, A. S., Eckardt, K.-U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., Zeeuw, D. D. E., Hostetter, T. H., Lameire, N., & Eknoyan, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00365.x · Cited by 3,946
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
Kyle, R. A., Gertz, M. A., Witzig, T. E., Lust, J. A., Lacy, M. Q., Dispenzieri, A., Fonseca, R., Rajkumar, S. V., Offord, J. R., Larson, D. R., et al. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.1.21 · Cited by 2,447 · cited 1×
“a serum creatinine above the upper limit of normal and the majority have a serum creatinine lower than 4 mg/dL.(11,13,14) In several series from tertiary hospitals, up to 10% of patients present with RI severe enough to require dialysis.”
BackgroundSelf-citationThe International Myeloma Working Group (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04355.x · Cited by 2,321
Improved survival in multiple myeloma and the impact of novel therapies
Kumar, S. K., Rajkumar, S. V., Dispenzieri, A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Zeldenrust, S. R., Dingli, D., Russell, S. J., Lust, J. A., et al. (2008) · Blood · doi:10.1182/blood-2007-10-116129 · Cited by 2,240
Self-citationGertz, M. A., Comenzo, R., Falk, R. H., Fermand, J. P., Hazenberg, B. P., Hawkins, P. N., Merlini, G., Moreau, P., Ronco, P., Sanchorawala, V., et al. (2005) · American Journal of Hematology · doi:10.1002/ajh.20381 · Cited by 1,428
Self-citationStevens, L. A., Coresh, J., Schmid, C. H., Feldman, H. I., Froissart, M., Kusek, J., Rossert, J., Van Lente, F., Bruce, R. D., Zhang, Y. (., et al. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.11.018 · Cited by 1,037
Augustson, B. M., Begum, G., Dunn, J. A., Barth, N. J., Davies, F., Morgan, G., Behrens, J., Smith, A., Child, J. A., & Drayson, M. T. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2086 · Cited by 488
Bladé, J., Fernández-Llama, P., Bosch, F., Montolíu, J., Lens, X. M., Montoto, S., Cases, A., Darnell, A., Rozman, C., & Montserrat, E. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.17.1889 · Cited by 383
Self-citationRenal failure in multiple myeloma: reversibility and impact on the prognosis
Knudsen, L. M., Hjorth, M., Hippe, E., & Nordic Myeloma Study Group (2000) · European Journal of Haematology · doi:10.1034/j.1600-0609.2000.90221.x · Cited by 380
Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function
KINTZEL, P. (1995) · Cancer Treatment Reviews · doi:10.1016/0305-7372(95)90010-1 · Cited by 357
Plasma Exchange When Myeloma Presents as Acute Renal Failure: A Randomized, Controlled Trial
Clark, W. F., Stewart, A. K., Rock, G. A., Sternbach, M., Sutton, D. M., Barrett, B. J., Heidenheim, A. P., Garg, A. X., Churchill, D. N., & and the Canadian Apheresis Group (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-11-200512060-00005 · Cited by 332
Results of autologous stem cell transplant in multiple myeloma patients with renal failure
Badros, A., Barlogie, B., Siegel, E., Roberts, J., Langmaid, C., Zangari, M., Desikan, R., Shaver, M. J., Fassas, A., McConnell, S., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03033.x · Cited by 306
Self-citationPathogenesis and treatment of renal failure in multiple myeloma
Dimopoulos, M. A., Kastritis, E., Rosinol, L., Bladé, J., & Ludwig, H. (2008) · Leukemia · doi:10.1038/leu.2008.131 · Cited by 305
Self-citationJohnson, W. J., Kyle, R. A., Pineda, A. A., O'Brien, P. C., & Holley, K. E. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.4.863 · Cited by 265
Screening for renal disease using serum creatinine: who are we missing?
Duncan, L., Heathcote, J., Djurdjev, O., & Levin, A. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.5.1042 · Cited by 258
Renal failure in multiple myeloma. Pathogenesis and prognostic implications
Alexanian, R. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.8.1693 · Cited by 257
Chanan-Khan, A. A., Kaufman, J. L., Mehta, J., Richardson, P. G., Miller, K. C., Lonial, S., Munshi, N. C., Schlossman, R., Tariman, J., & Singhal, S. (2007) · Blood · doi:10.1182/blood-2006-09-046409 · Cited by 256
Self-citationHutchison, C. A., Bradwell, A. R., Cook, M., Basnayake, K., Basu, S., Harding, S., Hattersley, J., Evans, N. D., Chappel, M. J., Sampson, P., et al. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04590908 · Cited by 253
Chen, N., Lau, H., Kong, L., Kumar, G., Zeldis, J. B., Knight, R., & Laskin, O. L. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007309563 · Cited by 248
Lichtman, S. M., Wildiers, H., Launay-Vacher, V., Steer, C., Chatelut, E., & Aapro, M. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.11.004 · Cited by 245
Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance
Eleutherakis-Papaiakovou, V., Bamias, A., Gika, D., Simeonidis, A., Pouli, A., Anagnostopoulos, A., Michali, E., Economopoulos, T., Zervas, K., & Dimopoulos on behalf of the Greek M, M. A. (2007) · Leukemia & Lymphoma · doi:10.1080/10428190601126602 · Cited by 231
Terpos, E., Sezer, O., Croucher, P. I., García-Sanz, R., Boccadoro, M., San Miguel, J., Ashcroft, J., Bladé, J., Cavo, M., Delforge, M., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn796 · Cited by 230
Self-citation[Renal failure in multiple myeloma].
Sicinski, A. M. (1986) · PubMed · Cited by 223
Jagannath, S., Barlogie, B., Berenson, J. R., Singhal, S., Alexanian, R., Srkalovic, G., Orlowski, R. Z., Richardson, P. G., Anderson, J., Nix, D., et al. (2005) · Cancer · doi:10.1002/cncr.20888 · Cited by 222
Self-citationTidman, M., Sjostrom, P., & Jones, I. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm661 · Cited by 193
Kastritis, E., Zervas, K., Symeonidis, A., Terpos, E., Delimbassi, S., Anagnostopoulos, N., Michali, E., Zomas, A., Katodritou, E., Gika, D., et al. (2009) · Leukemia · doi:10.1038/leu.2008.402 · Cited by 187
Self-citationSan-Miguel, J. F., Richardson, P. G., Sonneveld, P., Schuster, M. W., Irwin, D., Stadtmauer, E. A., Facon, T., Harousseau, J.-L., Ben-Yehuda, D., Lonial, S., et al. (2008) · Leukemia · doi:10.1038/sj.leu.2405087 · Cited by 185
Self-citationDimopoulos, M. A., Richardson, P. G., Schlag, R., Khuageva, N. K., Shpilberg, O., Kastritis, E., Kropff, M., Petrucci, M. T., Delforge, M., Alexeeva, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.2232 · Cited by 172
Self-citationMonitoring Renal Function and Limitations of Renal Function Tests
Prigent, A. (2008) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2007.09.003 · Cited by 170
Kastritis, E., Anagnostopoulos, Α., Ρούσσου, Μ., Gika, D., Matsouka, C., Barmparousi, D., Grapsa, I., Psimenou, E., Bamias, A., & Dimopoulos, M. A. (2007) · Haematologica · doi:10.3324/haematol.10759 · Cited by 169
Self-citationRenal Pathologic Spectrum in an Autopsy Series of Patients With Plasma Cell Dyscrasia
Herrera, G. A., Joseph, L., Gu, X., Hough, A. J., & Barlogie, B. (2004) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2004-128-875-rpsiaa · Cited by 144
Self-citationHUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITES
Pekol, T. M., Daniels, J. S., LaButti, J. N., Parsons, I., Nix, D., Baronas, E., Hsieh, F., Gan, L.-S. L., & Miwa, G. T. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002956 · Cited by 143
Şengül, Ş., Zwizinski, C. W., Simon, E. E., Kapasi, A. A., Singhal, P. C., & Batuman, V. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00660.x · Cited by 141
Uttamsingh, V., Lu, C., Miwa, G. T., & Gan, L.-S. L. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005710 · Cited by 139
Dimopoulos, M. A., Alegre, A. M., Stadtmauer, E. A., Goldschmidt, H., Zonder, J. A., de Castro, C. M., Masliak, Z., Reece, D. E., Olesnyckyj, M., Yu, Z., et al. (2010) · Cancer · doi:10.1002/cncr.25139 · Cited by 137
Self-citationModern Classification of Acute Kidney Injury
Srisawat, N., Hoste, E. A. J., & Kellum, J. A. (2010) · Blood Purification · doi:10.1159/000280099 · Cited by 136
Torrá, R., Bladé, J., Cases, A., López-Pedret, J., Montserrat, E., Rozmán, C., & Revert, L. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05400.x · Cited by 134
Self-citationReversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma
Ludwig, H. C., Drach, J. W., Graf, H., et al. (2007) · Haematologica · doi:10.3324/haematol.11463 · Cited by 132
Self-citationTsakiris, D., Stel, V. S., Finne, P., Fraser, E., Heaf, J. G., Meester, J. D., Schmaldienst, S., Dekker, F. W., Verrina, E. E., & Jager, K. J. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp679 · Cited by 131
Dimopoulos, M. A., Ρούσσου, Μ., Gavriatopoulou, M., Zagouri, F., Migkou, M., Matsouka, C., Barbarousi, D., Christoulas, D., Primenou, E., Grapsa, I., et al. (2009) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2009.n.059 · Cited by 121
Self-citationMapping the Binding Domain of Immunoglobulin Light Chains for Tamm-Horsfall Protein
Ying, W., & Sanders, P. W. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64142-9 · Cited by 120
Are myeloma patients with renal failure candidates for autologous stem cell transplantation?
Miguel, J. F. S., Lahuerta, J. J., García‐Sánz, R., Alegre, A. M., Bladé, J., Martínez, R. M. C., García‐Laraña, J., de la Rubia, J., Sureda, A. M., Vidal, M. J., et al. (2000) · The Hematology Journal · doi:10.1038/sj.thj.6200003 · Cited by 116
Self-citationTosi, P., Zamagni, E., Cellini, C., Cangini, D., Tacchetti, P., Tura, S., Baccarani, M., & Cavo, M. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00272.x · Cited by 112
Self-citationRenal, hematologic and infectious complications in multiple myeloma
Bladé, J., & Rosiñol, L. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2005.01.013 · Cited by 90
Self-citationEriksson, T., Höglund, P., Turesson, I., Waage, A., Don, B. R., Vu, J. T., Scheffler, M. R., & Kaysen, G. A. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022241 · Cited by 89
Niesvizky, R., Naib, T., Christos, P. J., Jayabalan, D. S., Furst, J. R., Jalbrzikowski, J., Zafar, F., Mark, T. M., Lent, R. W., Pearse, R. N., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06698.x · Cited by 88
Self-citationRole of MAPK pathways in light chain-induced cytokine production in human proximal tubule cells
Şengül, Ş., Zwizinski, C. W., & Batuman, V. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00350.2002 · Cited by 88
Harris, E., Behrens, J., Samson, D., Rahemtulla, A., Russell, N. H., & Byrne, J. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04395_2.x · Cited by 85
RAYNER, H., Haynes, A. P., Thompson, J., Russell, N. H., & FLETCHER, J. (1991) · QJM · doi:10.1093/oxfordjournals.qjmed.a068572 · Cited by 85
Morabito, F., Gentile, M., Ciolli, S., Petrucci, M. T., Galimberti, S., Mele, G., Casulli, A. F., Mannina, D., Piro, E., Pinotti, G., et al. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01385.x · Cited by 81
Self-citationParikh, G. C., Amjad, A. I., Saliba, R. M., Kazmi, S. M. A., Khan, Z. U., Lahoti, A., Hosing, C. M., Mendoza, F. L., Qureshi, S. R., Weber, D. M., et al. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2009.03.021 · Cited by 79
Self-citationΡούσσου, Μ., Kastritis, E., Christoulas, D., Migkou, M., Gavriatopoulou, M., Grapsa, I., Psimenou, E., Gika, D., Terpos, E., & Dimopoulos, M. A. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.04.024 · Cited by 72
Self-citationTerpos, E., Katodritou, E., Tsiftsakis, E., Kastritis, E., Christoulas, D., Pouli, A. G., Michalis, E., Verrou, E., Anargyrou, K., Tsionos, K., et al. (2009) · Haematologica · doi:10.3324/haematol.2008.000638 · Cited by 71
Self-citationDimopoulos, M. A., Christoulas, D., Ρούσσου, Μ., Kastritis, E., Migkou, M., Gavriatopoulou, M., Matsouka, C., Mparmparoussi, D., Psimenou, E., Grapsa, I., et al. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01432.x · Cited by 69
Self-citationBladé, J., Sonneveld, P., Miguel, J. F. S., Sutherland, H. J., Hájek, R., Nagler, A., Spencer, A. G., Robak, T., Cibeira, M. T., Zhuang, S. H., et al. (2008) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2008.n.051 · Cited by 59
Self-citationBIOLOGY AND THERAPY OF IMMUNOGLOBULIN DEPOSITION DISEASES
Dhodapkar, M. V., Merlini, G., & Solomon, A. (1997) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70417-2 · Cited by 52
Thalidomide in patients with multiple myeloma and renal failure
Fakhouri, F., Guerraoui, H., Presne, C., Peltier, J., Delarue, R., Muret, P., & Knebelmann, B. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04875.x · Cited by 46
Meeting the Unmet Needs in Anticoagulant Therapy
Weitz, J. I. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01461.x · Cited by 42
Estimation of renal function in patients with chronic kidney disease
Kooman, J. P. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21970 · Cited by 32
Paraproteinemic Renal Diseases that Involve the Tubulo-Interstitium
Herrera, G. A., & Sanders, P. W. (2006) · KARGER eBooks · doi:10.1159/000096763 · Cited by 30
Management of Complications in Multiple Myeloma
Terpos, E., Cibeira, M. T., Bladé, J., & Ludwig, H. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.01.005 · Cited by 30
Self-citationRenal recovery with lenalidomide in a patient with bortezomib-resistant multiple myeloma
Ludwig, H., & Zojer, N. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.31 · Cited by 16
Self-citationLynch, H. T., & Thomé, S. D. (2009) · Blood · doi:10.1182/blood-2009-03-207233 · Cited by 16
Cited by
Kumar, S. K., Rajkumar, V., Kyle, R. A., van Duin, M., Sonneveld, P., Mateos, M.-V., Gay, F., & Anderson, K. C. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.46 · Cited by 1,177
Self-citationEuropean Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Terpos, E., Kleber, M., Engelhardt, M., Zweegman, S., Gay, F., Kastritis, E., van de Donk, N. W. C. J., Bruno, B., Sezer, O., Broijl, A., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.117176 · Cited by 988
Self-citationMultiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Moreau, P., San Miguel, J., Sonneveld, P., Mateos, M. V., Zamagni, E., Avet-Loiseau, H., Hajek, R., Dimopoulos, M. A., Ludwig, H., Einsele, H., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx096 · Cited by 877
Self-citationSonneveld, P., Schmidt-Wolf, I. G. H., van der Holt, B., el Jarari, L., Bertsch, U., Salwender, H., Zweegman, S., Vellenga, E., Broyl, A., Blau, I. W., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.6820 · Cited by 824
Self-citationMultiple Myeloma: Diagnosis and Treatment
Rajkumar, S. V., & Kumar, S. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.11.007 · Cited by 812
Self-citation
Metadata
- Authors
- Dimopoulos, M. A., Terpos, E., Chanan-Khan, A., Leung, N., Ludwig, H., Jagannath, S., Niesvizky, R., Giralt, S., Fermand, J.-P., Bladé, J., Comenzo, R. L., Sezer, O., Palumbo, A., Harousseau, J.-L., Richardson, P. G., Barlogie, B., Anderson, K. C., Sonneveld, P., Tosi, P., Cavo, M., Rajkumar, S. V., Durie, B. G. M., & San Miguel, J.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-11-20
- Volume
- 28
- Issue
- 33
- Pages
- 4976-4984
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1998723844
- Cited by
- 414
- References
- 66
- FWCI
- 20.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.